Michael R. Hamrell

Ph.D., RAC, FRAPS, RQAP-GCP, CCRA

Dr. Michael R. Hamrell is the President of MORIAH Consultants, a Regulatory Affairs/Clinical Research consulting firm located near Los Angeles, CA. He has worked in drug development, clinical research and regulatory affairs for over 30 years. He has worked in pharmaceuticals, contract research, government, and biotech industries, in domestic and international regulatory affairs and clinical research. Dr. Hamrell also worked in the Division of AIDS in NIAID at the National Institutes of Health, and as a reviewer in the Center for Drug Evaluation & Research at the Food and Drug Administration (FDA), in the Divisions of Antiviral Drug Products, Oncology Drug Products, and Bioequivalence.

Dr. Hamrell spent a number of years doing basic research, first as a Research Fellow at Duke University and later as an Assistant Professor of Pharmacology at the McGill University Cancer Center. Dr. Hamrell has a Ph.D. degree in Pharmacology from the University of Southern California and a B.S. in Biochemistry from the University of California, Los Angeles. Dr. Hamrell has received numerous awards for his research, teaching and professional work and is recognized in Who's Who. Dr. Hamrell also holds an appointment as Adjunct Professor of Molecular Pharmacology and Toxicology at the University of Southern California School of Pharmacy, as Adjunct Instructor at Eastern Michigan University Clinical Research Program and as Adjunct Professor at the Massachusetts College of Pharmacy & Health Sciences.

He has published numerous papers in pharmacology, regulatory affairs, product development, clinical research, computers and information systems. Dr Hamrell served as a founding Editorial Board member for Applied Clinical Trials and RA FOCUS, as the founding editor of the DIA Forum and as the Editor-in-Chief of the Drug Information Journal and Editor-in-Chief of the GCP Q&A Reference Guide. He currently serves as a member of the Editorial Board of DIA Global Forum, Applied Clinical Trials, ACRP ClinicalResearcher.

마이클 R. 함렐 박사는 인허가 업무 및 임상 연구 컨설팅 회사인 Moriah Consultants(미국 캘리포니아)의 대표로 신약 개발, 임상 연구 및 인허가 분야에서 30년 이상 일했다.

함렐 박사는 미 국립 보건원(NIH) 및 식품의약국(FDA)에서 근무했으며, 인허가와 의약품 개발, 임상연구 분야에서 수많은 논문을 발표했다.

현재 DIA 글로벌 포럼의 편집위원으로 활동하고 있는 현장경험이 풍부한 교육 전문가다.